These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36891896)

  • 1. Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression.
    Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
    Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.
    Xue C; Li G; Lu J; Li L
    Signal Transduct Target Ther; 2021 Nov; 6(1):400. PubMed ID: 34815385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the dual role of circRNA and PI3K/AKT pathway in tumors of the digestive system.
    Li P; Huang D; Gu X
    Biomed Pharmacother; 2023 Dec; 168():115694. PubMed ID: 37832407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs Involved in the Regulation of the Age-Related Pathways.
    Wang S; Xiao F; Li J; Fan X; He Z; Yan T; Yang M; Yang D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 6. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
    Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
    Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression.
    Karami Fath M; Akhavan Masouleh R; Afifi N; Loghmani S; Tamimi P; Fazeli A; Mousavian SA; Falsafi MM; Barati G
    Pathol Res Pract; 2023 Jan; 241():154279. PubMed ID: 36584499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis.
    Jin T; Wang H; Liu Y; Wang H
    J Mol Med (Berl); 2024 Mar; 102(3):313-335. PubMed ID: 38265445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
    Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
    Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; V├ęzina A; Villeneuve L; Vachon PH
    J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
    Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
    Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
    Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y
    Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ_0006089 promotes the progression of gastric cancer by regulating the miR-143-3p/PTBP3 axis and PI3K/AKT signaling pathway.
    Lin GR; Chen WR; Zheng PH; Chen WS; Cai GY
    J Dig Dis; 2022 Jul; 23(7):376-387. PubMed ID: 35844201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.